Delivery Order SPE2DB22D2218-SPE2DB25FR2DE
Award Date
3/14/25
Potential Completion Date
3/17/25
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of VRAYLAR 1.5 MG CAPSULE 30S. The $6,622.44 Firm Fixed Price contract has a completion date of September 26, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999 through December 2025, which serves as the primary vehicle for providing a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,002.86, is a delivery order with a firm fixed price for the supply of VRAYLAR 1.5 MG CAPSULE 30S to support military healthcare programs. The contract has an ultimate completion date of February 25, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VRAYLAR 1.5 MG CAPSULE 30S. The contract has a ceiling value of $6,200.17 and a completion date of September 12, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,197.25, is for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a prescription medication. The contract has a completion date of January 24, 2025 and is a firm fixed-price contract. The contract was not set aside for any specific business category. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of VRAYLAR 3 MG CAPSULE 30S. The contract has a ceiling value of $18,800.05 and runs through September 4, 2024. It is a firm fixed price contract with no set-aside designation. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, such as the Department of Justice Federal Bureau...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $11,636.87 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VRAYLAR 1.5 MG CAPSULE 30S. This contract, with a completion date of March 6, 2024, is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $7,801.34, is for the delivery of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product, with a completion date of March 8, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VRAYLAR 1.5 MG CAPSULE 30S. The contract has a firm fixed price of $11,694.89 and a period of performance through August 7, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which provides a comprehensive range of...
This is a Delivery Order federal contract award made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,025.59, is for the provision of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. The contract is a Firm Fixed Price type with a performance period through January 31, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,668.83 firm fixed-price delivery order is for the supply of 4566660815 VRAYLAR 1.5 MG CAPSULE 30S, with a completion date of December 10, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...